Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited ... manufacture of sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir for distribution ...

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Zydus Lifesciences Limited ( ($IN:ZYDUSLIFE) ) has shared an update. Zydus Lifesciences Limited has received final approval from the USFDA to ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

Revealing that the company initiated the Class-II nationwide (US) recall on February 6, 2025, the USFDA reported that Zydus ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Methenamine Hippurate Tablets.

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...